CEO SUMMARY: In July, the federal Centers for Medicare & Medicaid Services (CMS) published three proposed rules which would allow it to act independently of Congress to set prices for clinical laboratory testing and pathology services. Analyses of these proposed rules indicate that they would substantially reduce reimbursement paid to labs and pathologists under existing …
CMS Ready To Hack Away at Cost of Lab Testing Read More »
